Care Coordinators Cut Costs, Improve Health Outcomes, But Are Underused

A few years ago, patient navigators at Project Access-New Haven set out to see if they could change the course of health care treatment for some Medicaid patients who frequently used emergency rooms.

They contacted emergency departments at Yale New Haven Hospital and its Saint Raphael campus and enrolled 100 patients in their study in 2013. Those selected had visited emergency rooms four to 18 times in the past year for chest pain, abdominal pain or chronic migraines, among other ailments. The navigators at Project Access coordinated health care for the patients. They scheduled appointments with primary care physicians, provided reminders, accompanied patients to physician visits and followed up to ensure compliance with the prescribed treatment. The preliminary results were eye-opening: “We saw an average cost reduction of $153 per member per month,” said Dr. Roberta Capp, assistant professor, Department of Emergency Medicine at the University of Colorado Denver, and lead investigator of the study.

Female Surgeons Making Inroads In Male-Dominated Operating Rooms

When the lights power on in the operating room at Bridgeport Hospital, more than a half of the acute care team of surgeons peering from behind the masks are women. That’s unusual, given that only 28 percent of all surgeons in Connecticut are female, according to the latest figures from the American Medical Association (AMA). Flexible work schedules and hiring more surgeons to ease the on-call burden has helped to lure more women to the trauma surgical team, said Bridgeport Hospital’s chief medical officer, Dr. Michael Ivy, a trauma surgeon. Hospitals statewide have launched initiatives to help boost the ranks of women surgeons. There’s been progress, but gaps persist.

Clinical Trials In Need Of Diversity

Edith Baker of Plainville faced a devastating reality that patients with advanced cancer inevitably confront. She had stopped responding to conventional treatment. Radiation and chemotherapy could no longer contain her stage 4 bladder cancer. But there was a ray of hope. Baker’s oncologist at Saint Francis Hospital and Medical Center referred her to a clinical trial at UConn Health involving two immunotherapy drugs: the FDA-approved Keytruda (pembrolizumab) from Merck & Co., credited with successfully treating former President Jimmy Carter’s melanoma; and Epacadostat (IDO1 inhibitor), an experimental drug from Incyte Corp.

OSHA Penalties Drop Nearly 50 Percent In Five Years

Penalties levied against Connecticut companies for violations of occupational safety rules dropped by more than half between 2011 and 2015, and the number of cases with penalties fell by 40 percent in the same time period, according to a C-HIT analysis of federal Occupational Safety & Health Administration (OSHA) data. Data from the agency’s offices in Bridgeport and Hartford show initial penalties against Connecticut employers totaled $10.86 million in 2011 and dropped to $5.07 million in 2015. Companies were able to negotiate settlements, lowering penalty payments to $6.26 million in 2011, and $3.51 million in 2015. For the first nine months of 2016, the downward trends in cases and fines are continuing, the data show. Reasons for the declines vary: Government officials point to safer workplaces and more compliance with regulations.